妊娠期SARS-CoV-2感染与母婴结局的关联
CANCOVID-Preg是加拿大6个省份2020年3月1日至2021年10月31日的观察性监测项目,纳入6012例妊娠期SARS-CoV-2 PCR阳性者,与年龄匹配的感染女性及同期未感染孕妇比较。妊娠期感染者的SARS-CoV-2相关住院率为7.75%,高于加拿大20-49岁普通女性感染者的2.93%(RR 2.65,95%CI 2.41-2.88);ICU/重症监护入住率为2.01% vs 0.37%(RR 5.46,95%CI 4.50-6.53)。早产风险在感染孕妇中升高(11.05% vs 6.76%,RR 1.63,95%CI 1.52-1.76),轻症不需住院者亦然。年龄增长、既往高血压和诊断时孕周较大与更差母体结局相关。
要点
- 妊娠期SARS-CoV-2感染者住院风险为7.75%,高于普通育龄女性感染者的2.93%(RR 2.65,95%CI 2.41-2.88)。
- 妊娠期感染者ICU/重症监护入住率为2.01%,高于普通女性感染者的0.37%(RR 5.46,95%CI 4.50-6.53)。
- 感染孕妇早产率为11.05%,高于同期未感染孕妇的6.76%(RR 1.63,95%CI 1.52-1.76),轻症不需住院者亦升高。
- 年龄增长、既往高血压、诊断时孕周较大与更差母体结局显著相关。
- 35.7%的病例在孕28-37周确诊,非白人个体比例过高。
适用人群与场景
- 加拿大6个省份2020年3月1日至2021年10月31日妊娠期任何时间SARS-CoV-2 PCR检测阳性的孕妇6012例(中位年龄31岁,IQR 28-35),主要为有症状就诊者。
- 对照为年龄匹配的SARS-CoV-2感染女性及大流行期间未感染的孕妇。
研究设计与关键结果
- 观察性监测项目(CANCOVID-Preg),加拿大6个省份,2020年3月1日至2021年10月31日,纳入6012例妊娠期SARS-CoV-2 PCR阳性者,与2个同期对照组合比较。
- 妊娠期感染者SARS-CoV-2相关住院率7.75%,高于加拿大20-49岁普通女性感染者的2.93%(RR 2.65,95%CI 2.41-2.88)。
- 妊娠期感染者ICU/重症监护入住率2.01%,高于普通女性感染者的0.37%(RR 5.46,95%CI 4.50-6.53)。
- 感染孕妇早产率11.05%,高于同期未感染孕妇的6.76%(RR 1.63,95%CI 1.52-1.76),轻症不需住院者亦升高。
- 年龄增长、既往高血压、诊断时孕周较大与更差母体结局显著相关。
- 35.7%的病例在孕28-37周确诊;非白人个体比例过高。
证据类型、等级与局限
- 证据类型:观察性监测项目(探索性、人群水平数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,妊娠期SARS-CoV-2感染与母体不良结局及早产风险显著升高相关,即使轻症不需住院者早产风险亦升高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There are limited high-quality, population-level data about the effect of SARS-CoV-2 infection on pregnancy using contemporaneous comparator cohorts.
OBJECTIVES: To describe maternal and perinatal outcomes associated with SARS-CoV-2 infection in pregnancy and to assess variables associated with severe disease in the pregnant population.
DESIGN, SETTING, AND PARTICIPANTS: CANCOVID-Preg is an observational surveillance program for SARS-CoV-2-affected pregnancies in Canada. This analysis presents exploratory, population-level data from 6 Canadian provinces for the period of March 1, 2020, to October 31, 2021. A total of 6012 pregnant persons with a positive SARS-CoV-2 polymerase chain reaction test result at any time in pregnancy (primarily due to symptomatic presentation) were included and compared with 2 contemporaneous groups including age-matched female individuals with SARS-CoV-2 and unaffected pregnant persons from the pandemic time period.
EXPOSURE: SARS-CoV-2 infection during pregnancy. Incident infections in pregnancy were reported to CANCOVID-Preg by participating provinces/territories.
MAIN OUTCOMES AND MEASURES: Maternal and perinatal outcomes associated with SARS-CoV-2 infection as well as risk factors for severe disease (ie, disease requiring hospitalization, admission to an intensive care unit/critical care unit, and/or oxygen therapy).
RESULTS: Among 6012 pregnant individuals with SARS-CoV-2 in Canada (median age, 31 [IQR, 28-35] years), the greatest proportion of cases were diagnosed at 28 to 37 weeks' gestation (35.7%). Non-White individuals were disproportionately represented. Being pregnant was associated with a significantly increased risk of SARS-CoV-2-related hospitalization compared with SARS-CoV-2 cases among all women aged 20 to 49 years in the general population of Canada (7.75% vs 2.93%; relative risk, 2.65 [95% CI, 2.41-2.88]) as well as an increased risk of intensive care unit/critical care unit admission (2.01% vs 0.37%; relative risk, 5.46 [95% CI, 4.50-6.53]). Increasing age, preexisting hypertension, and greater gestational age at diagnosis were significantly associated with worse maternal outcomes. The risk of preterm birth was significantly elevated among SARS-CoV-2-affected pregnancies (11.05% vs 6.76%; relative risk, 1.63 [95% CI, 1.52-1.76]), even in cases of milder disease not requiring hospitalization, compared with unaffected pregnancies during the same time period.
CONCLUSIONS AND RELEVANCE: In this exploratory surveillance study conducted in Canada from March 2020 to October 2021, SARS-CoV-2 infection during pregnancy was significantly associated with increased risk of adverse maternal outcomes and preterm birth.
参考来源
- McClymont E, Albert AY, Alton GD, et al. Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes. JAMA. 2022. PMID: 35499852. doi:10.1001/jama.2022.5906
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。